Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

http://www.novavax.com


NVAX $0.54 -0.09 (-14.29%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 240 Million
EPS -0.12 P/E Ratio 0.00
Previous Earnings Wed, Aug 8, 2018
Latest Earnings Wed, Nov 7, 2018
Dividend --
Ex-Date --
Dividend Pay Date --
Dividend History --

0.54 0.24 0.00 0.00 NVAX NASDAQ -14.29 -72.59 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NVAX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NVAX&exchange=NASDAQ&chart=1

Symbol Surfing has been referenced on Barrons, CNN & Investor Place.

About | Blog | Advertising | Terms | info@symbolsurfing.com

Investing Quotes #Legendary


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.

©2019 Symbol Surfing All Rights Reserved. Privacy Policy | ^Top